New antihyperglycemic, α-glucosidase inhibitory, and cytotoxic derivatives of benzimidazoles

References

• Kohler P. The biochemical basis of anthelmintic action and resistance. Int J Parasitol 2001;31:336–45.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Nishigaki N, Washio Y, Kano K, Harris PA, Sato H, et al. Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptor. J Med Chem 2007;50:4453–70.
   PubMed Web of Science ®Google Scholar
• Hranjec M, Kralji M, Piantanida I, Sedic M, Suman L, Pvelic K, et al. Novel cyno and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2-a]quinolines. Synthesis, photochemical synthesis, DNA binding, and antitumor evaluation, Part 3. J Med Chem 2007;50:5696–711.
   PubMed Web of Science ®Google Scholar
• Safonov IG, Heerding DA, Keenan RM, Price AT, Ericson-Miller CL, Hopson CB, et al. New benzimidazoles as thrombopoietin receptor agonists. Bioorg Med Chem Lett 2006;16:1212–16.
   PubMed Web of Science ®Google Scholar
• Falco JL, Pique M, Gonzalez M, Buira I, Mendez E, Terencio J, et al. Synthesis, pharmacology and molecular modeling of N-substituted 2-phenyl-indoles and benzimidazoles as potent GABAA agonists. Eur J Med Chem 2006;41:985–90.
   PubMed Web of Science ®Google Scholar
• Siva Kumar BV, Vaidya SD, Vinod Kumra R, Bhirud SB, Mane RB. Synthesis and anti-bacterial activity of some novel 2-(6-fluorochroman-2-yl)-1-alkyl/acyl/aroyl-1H-benzimidazoles. Eur J Med Chem 2006;41:599–604.
   PubMed Web of Science ®Google Scholar
• Navarette-Vazquez N, Rojano-Vilchis MM, Yepez-Mulia L, Melendez V, Gerena L, Hernandez-Campos A, et al. Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres. Eur J Med Chem 2006;41:135–41.
   PubMed Web of Science ®Google Scholar
• Kazimierczuk Z, Rzejewska M, Kaustova J, Klimesova V. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles. Eur J Med Chem 2005;40:203–8.
   PubMed Web of Science ®Google Scholar
• Kim JS, Sun Q, Gatto B, Yu C, Liu A, Liu LF, et al. Structure-activity relationship of benzimidazoles and related heterocycles as topoisomerase I inhibitors. Bioorg Med Chem 1996;4:621–30.
   PubMed Web of Science ®Google Scholar
• Zarrinmayeh H, Zimmerman D M, Cantrell B E, Schober D A, Bruns R F. Structure-activity relationship of series of diaminoalkyl substituted benzimidazole as neuropeptide YY1 receptor antagonists. Bioorg Med Chem Lett 1999;9:647–52.
   PubMed Web of Science ®Google Scholar
• Kohara Y, Kubo K, Imamiya E, Wada T, Inada Y, Naka T. Synthesis and angiotensin II receptor antagonist activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosters. J Med Chem 1996;39:5228–35.
   PubMed Web of Science ®Google Scholar
• Wallace MB, Feng J, Zhang Z, Skene RJ, Shi L, Caster CL, et al. Structure based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett 2008;18:2362–7.
   PubMed Web of Science ®Google Scholar
• Minoura H, Takeshita S, Ita M, Hirosumi J, Mbuchi M, Kawamura I, et al. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer FK 614. Eur J Pharmacol 2004;494:273–81.
   PubMed Web of Science ®Google Scholar
• Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, et al. Mechanism by which a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK 614, ameliorates insulin resistance in Zucker fatty rats. Diabetes Obes Metab 2007;9:369–78.
   PubMed Web of Science ®Google Scholar
• Carroll MF, Gutierrez A, Castro M, Tsewang D, Schade DS. Targeting postprandial hyperglycemia: a comparative study of insulin tropic agents in type 2 diabetes. J Clin Endocrinol Metab 2003;88:5248–54.
   PubMed Web of Science ®Google Scholar
• Boutati EI, Raptis SA. Postprandial hyperglycemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice. Diabetes Metab Res Rev 2004;20:S13–23.
   PubMed Web of Science ®Google Scholar
• Berseter JM, Goke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 2008;114:84–98.
   PubMedGoogle Scholar
• Reddy SV, Tiwari AK, Kumar US, Rao JR, Rao JM. Free radical scavenging, enzyme inhibitory constituents from antidiabetic Ayurvedic medicinal plant Hydnocarpus wigtiana Blume. Phytother Res 2005;19:277–81.
   PubMed Web of Science ®Google Scholar
• Gowri PM, Tiwari AK, Ali AZ, Rao JM. Inhibition of α-glucosidase and amylase by bartogenic acid isolated from Barringtonia racemosa Roxb. seeds. Phytother Res 2007;21:796–9.
   PubMed Web of Science ®Google Scholar
• Kamal A, Tekumalla V, Raju P, Naidu VGM, Diwan PV, Sistala R. Pyrrolo[2,1-c][1,4]benzodiazepine-β-glucuronide prodrugs with a potential for selective therapy of solid tumors by PMT and ADEPT strategies. Bioorg Med Chem Lett 2008;18:3769–73.
   PubMed Web of Science ®Google Scholar
• Tiwari AK, Kumbhare RM, Agawane SB, Ali AZ, Kumar KV. Reduction in postprandial hyperglycemic excursion through α-glucosidase inhibition by β-acetamido carbonyl compounds. Bioorg Med Chem Lett 2008;18:4130–2.
   PubMed Web of Science ®Google Scholar
• Phillips MA. The formation of 2-substituted benziminazoles. J Chem Soc 1928:2393–9.
   Google Scholar
• Preston PN. Benzimidazoles and congeneric trycyclic compounds. In: Weissberger A, Tayler EC eds. The Chemistry of Heterocyclic Compounds. New York: Wiley, 1981;40:6–60.
   Google Scholar
• Dubey PK, Ratnam CV. Synthesis and spectra of 2-styryl-1H-imidazole[4,5-b]pyridines. Indian J Chem B 1979;18:428–31.
   Google Scholar
• Kim BH, Han R, Kim JS, Jun YM, Baik W, Lee BM. Indium-mediated reductive intermolecular coupling reaction of 2-nitroaniline with aromatic aldehydes to benzimidazoles. Heterocycles 2004;63:41–54.
   Web of Science ®Google Scholar
• Yin L, Liebscher J. Carbon-carbon coupling reactions catalyzed by heterogeneous palladium catalysts. Chem Rev 2007;107:133–73.
   PubMed Web of Science ®Google Scholar
• Ashok Kumar J, China Raju B. Manuscript under consideration in European Journal of Medicinal Chemistry. An efficient strategy for the synthesis of benzimidazoles using Pd (II) catalyst. 2008
   Google Scholar
• Gangadasu B, Narender P, Kumar SB, Ravinder M, Rao BA, Ramesh C, et al. Facile and selective synthesis of chloronicotinaldehydes by the Vilsmeier reaction. Tetrahedron 2006;62:8398–403.
   Web of Science ®Google Scholar
• Gloster TM, Meloncelli P, Stick RV, Zechel D, Vasella A, Davies GJ. Glycosidase inhibition: an assessment of the binding of 18 putative transition state mimics. J Am Chem Soc 2007;129:2345–54.
   PubMed Web of Science ®Google Scholar
• Chiba S. Molecular mechanism in α-glucosidase and glucoamylase. Biosci Biotechnol Biochem 1997;61:1233–9.
   PubMed Web of Science ®Google Scholar
• Asano N. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 2003;13:93R–104R.
   PubMed Web of Science ®Google Scholar
• Matsui T, Ogunwande IA, Abesundara KJM, Matsumoto K. Anti-hyperglycemic potential of natural products. Mini-Rev Med Chem 2006;6:109–20.
   PubMed Web of Science ®Google Scholar
• Kimura A. Molecular anatomy of α-glucosidase. Trends Glycosci Glycotechnol 2000;12:373–80.
   Web of Science ®Google Scholar
• Hakamata W, Muroi M, Kadokura K, Nishio T, Oku T, Kimur A, et al. Aglycon specificity profiling of α-glucosidases using synthetic probes. Bioorg Med Chem Lett 2005;15:1489–92.
   PubMed Web of Science ®Google Scholar
• O’Keefe JH, Bell DSH. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007;100:899–904.
   PubMed Web of Science ®Google Scholar
• Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutter GE, Van Weel C. Alpha-glucosidase inhibitors for patients with type 2 diabetes. Diabetes Care 2005;28:154–62.
   PubMed Web of Science ®Google Scholar
• Maki KC, Carlson ML, Miller MP, Turowski M, Bell M, Wilder DM, et al. High viscosity hydroxypropylmethyl cellulose blunts post- prandial glucose and insulin responses. Diabetes Care 2007;30:1039–43.
   PubMed Web of Science ®Google Scholar